JP2005514940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514940A5 JP2005514940A5 JP2003561519A JP2003561519A JP2005514940A5 JP 2005514940 A5 JP2005514940 A5 JP 2005514940A5 JP 2003561519 A JP2003561519 A JP 2003561519A JP 2003561519 A JP2003561519 A JP 2003561519A JP 2005514940 A5 JP2005514940 A5 JP 2005514940A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- amino acid
- acid sequence
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34951102P | 2002-01-18 | 2002-01-18 | |
| US36050002P | 2002-02-28 | 2002-02-28 | |
| US36504102P | 2002-03-15 | 2002-03-15 | |
| US37406302P | 2002-04-19 | 2002-04-19 | |
| US40346802P | 2002-08-14 | 2002-08-14 | |
| US41426202P | 2002-09-27 | 2002-09-27 | |
| US41998602P | 2002-10-21 | 2002-10-21 | |
| US42380902P | 2002-11-05 | 2002-11-05 | |
| US42979702P | 2002-11-26 | 2002-11-26 | |
| PCT/US2003/001450 WO2003061573A2 (en) | 2002-01-18 | 2003-01-16 | Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005514940A JP2005514940A (ja) | 2005-05-26 |
| JP2005514940A5 true JP2005514940A5 (cg-RX-API-DMAC7.html) | 2006-02-16 |
Family
ID=27618013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003561519A Pending JP2005514940A (ja) | 2002-01-18 | 2003-01-16 | １４３５分子、５５９分子、３４０２１分子、４４０９９分子、２５２７８分子、６４１分子、２６０分子、５５０８９分子、２１４０７分子、４２０３２分子、４６６５６分子、６２５５３分子、３０２分子、３２３分子、１２３０３分子、９８５分子、１３２３７分子、１３６０１分子、１８９２６分子、３１８分子、２０５８分子または６３５１分子を用いる泌尿器疾患を処置するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20030148394A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1472376A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005514940A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003210554A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003061573A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003057898A2 (en) * | 2001-12-31 | 2003-07-17 | Algos Therapeutics, Inc. | Methods and materials for modulating p2x2 |
| AU2003279308A1 (en) * | 2002-11-04 | 2004-06-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) |
| US8187810B2 (en) * | 2007-05-16 | 2012-05-29 | Wellman Wai-Man Cheung | Method for diagnosing overactive bladder |
| WO2010059971A1 (en) * | 2008-11-21 | 2010-05-27 | Martin Heath Bluth | Diagnosing and monitoring response to treatment of non-incontinent urological and related diseases |
| WO2025166351A1 (en) * | 2024-02-01 | 2025-08-07 | Massachusetts Eye And Ear Infirmary | Compositions and methods for hearing loss |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233421T2 (de) * | 1991-06-21 | 2006-02-23 | The Walter And Eliza Hall Institute Of Medical Research, Parkville | Neuartige rezeptor-typ tyrosinkinase und deren verwendung |
| US6242216B1 (en) * | 1997-11-14 | 2001-06-05 | Abbott Laboratories | Nucleic acids encoding a functional human purinoreceptor P2X2 and P2X4, and methods of production and use thereof |
| WO1999037811A1 (en) * | 1998-01-21 | 1999-07-29 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| US6780596B2 (en) * | 1998-09-17 | 2004-08-24 | Ashni Naturaceuticals, Inc. | Methods for determining the activity of complex mixtures |
| WO2000050589A1 (en) * | 1999-02-22 | 2000-08-31 | Ludwig Institute For Cancer Research | TYROSINE KINASE RECEPTOR EphA3 ANTIGENIC PEPTIDES |
| GB9926805D0 (en) * | 1999-11-13 | 2000-01-12 | Zeneca Ltd | Diagnostic methods |
| US6413757B1 (en) * | 2000-02-28 | 2002-07-02 | Millennium Pharmaceuticals, Inc. | 25312, a novel human agmatinase-like homolog |
| CA2411601A1 (en) * | 2000-06-05 | 2001-12-13 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
| AUPQ968700A0 (en) * | 2000-08-28 | 2000-09-21 | Intreat Pty Limited | Treatment of urinary incontinence |
| US20070014801A1 (en) * | 2001-01-24 | 2007-01-18 | Gish Kurt C | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| US20020111302A1 (en) * | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
| AU2002246708A1 (en) * | 2000-12-15 | 2002-08-12 | Agensys, Inc. | Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer |
-
2003
- 2003-01-16 EP EP03731962A patent/EP1472376A4/en not_active Withdrawn
- 2003-01-16 AU AU2003210554A patent/AU2003210554A1/en not_active Abandoned
- 2003-01-16 JP JP2003561519A patent/JP2005514940A/ja active Pending
- 2003-01-16 US US10/345,680 patent/US20030148394A1/en not_active Abandoned
- 2003-01-16 WO PCT/US2003/001450 patent/WO2003061573A2/en not_active Ceased
-
2005
- 2005-12-14 US US11/302,678 patent/US20060088881A1/en not_active Abandoned